Taken together, these findings highlight the potential efficacy of β-elemene as a novel approach to overcome lncRNA H19-mediated autophagy-induced degradation of EGFR and combat resistance to gefitinib in lung cancer. The gene discussed is EGFR; the disease is lung carcinoma.